Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies ; volume:8 ; number:1 ; day:13 ; month:9 ; year:2013 ; pages:1 ; date:9.2013
Molecular neurodegeneration ; 8, Heft 1 (13.9.2013), 1, 9.2013
- Urheber
-
Trojanowski, John Q.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-8-S1-O37
- URN
-
urn:nbn:de:1111-2016073073343
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Trojanowski, John Q.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Earlier Alzheimer’s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading
Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau